- Home
- Women Care
- Breast Cancer
- Abemaciclib 150 mg (Generic)


Abemaciclib 150 mg (Generic)
| Active Ingredient | Abemaciclib |
|---|---|
| Indication: | Treatment of metastatic breast cancer |
| Manufacturer: | Eli Lilly and Company India |
| Packaging: | 7 Tablets in Blister |
| Strength: | 150mg |
| Delivery Time: | 6 To 15 days |
Write a review

Abemaciclib 150 mg (Generic) | ||||
|---|---|---|---|---|
| 150mg | Price | Price/unit | Qty | Cart |
| 7 Tablet/s | $230.00 | $32.86 / Tablet | ||
| 14 Tablet/s | $400.00 | $28.57 / Tablet | ||
| 28 Tablet/s | $750.00 | $26.79 / Tablet | ||
Alternative Medicine
View MoreWhat is Abemaciclib 150 mg?
Abemaciclib 150 mg is a prescription medication developed by Eli Lilly and Company India, primarily used in the treatment of metastatic breast cancer. It contains the active ingredient Abemaciclib, which belongs to a class of drugs called cyclin-dependent kinase (CDK) inhibitors. This medicine is designed to slow down cancer cell growth and proliferation, making it an important option for patients battling advanced stages of breast cancer.
Metastatic breast cancer refers to cancer that has spread beyond the breast to other parts of the body. Managing this condition requires targeted and effective treatment options. Abemaciclib 150 mg plays a critical role by interfering with cancer cell division, thereby helping to control tumour progression.
The formulation of Abemaciclib at a 150 mg dosage is intended for daily use under medical supervision. It is often prescribed in combination with other therapies to improve treatment outcomes. Being a product of Eli Lilly and Company India ensures high manufacturing standards and reliable quality, making it a trusted choice among healthcare professionals and patients alike.
Abemaciclib 150 mg has gained recognition globally, including in Malaysia, where metastatic breast cancer continues to challenge patients and clinicians. Its approval and availability provide hope for effective management of this aggressive cancer subtype.
Uses of Abemaciclib 150 mg
- Treatment of hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer.
- Helps slow the progression of metastatic breast cancer.
- Can be used in combination with endocrine therapies.
- Used in patients who have experienced disease advancement following prior hormone therapy.
How Abemaciclib 150 mg Works
Abemaciclib 150 mg works by selectively inhibiting cyclin-dependent kinases 4 and 6 (CDK4/6), which are enzymes crucial for cell cycle progression. These enzymes regulate the transition from the G1 phase to the S phase of the cell cycle, a key step in cell replication.
By blocking CDK4/6 activity, Abemaciclib causes cell cycle arrest, effectively halting the growth and division of cancer cells. This mechanism targets malignant cells while sparing normal cells to some extent, thereby reducing tumour growth and spread.
This targeted action makes Abemaciclib an effective therapeutic agent for certain types of breast cancer, particularly those dependent on hormone receptor pathways. It complements hormone therapies, which address cancer cell growth signals, thereby improving overall treatment efficacy.
How to take Abemaciclib 150 mg
Abemaciclib 150 mg should be taken exactly as prescribed by your oncologist or healthcare provider. The medication is typically administered orally in the form of tablets.
- Swallow the tablet whole with water; do not crush or chew.
- Take it at the same time each day to maintain consistent blood levels.
- Can be taken with or without foodโfollow your doctorโs specific advice.
- Do not miss doses; if a dose is missed, take it as soon as you remember unless it is close to the time for the next dose.
- Report any difficulty in swallowing or intolerance to the medication to your healthcare provider immediately.
Benefits of Abemaciclib 150 mg
- Effective control of metastatic breast cancer progression.
- Targets cancer cells specifically, minimizing damage to normal cells.
- Improved patient outcomes when combined with hormone therapy.
- Oral administration offers convenient treatment over intravenous options.
- Well-studied safety profile and approved by health authorities.
Dosage and Administration
The recommended dose of Abemaciclib 150 mg is based on individual patient factors and should be confirmed by a healthcare professional. Typically, it is taken twice daily, approximately 12 hours apart.
Dosage adjustments may be necessary in cases of side effects or liver impairment. Patients should be closely monitored for blood counts and other laboratory parameters during treatment.
Adherence to prescribed dosage and schedule is critical to maximize treatment benefits and reduce risks of adverse effects.
Who Should Use Abemaciclib 150 mg?
Abemaciclib 150 mg is intended for adult patients diagnosed with hormone receptor-positive, HER2-negative metastatic breast cancer. It is suitable for those who have disease progression following endocrine therapy or as part of initial combination treatment under medical supervision.
Patients must be evaluated by an oncologist to determine if their cancer subtype and overall health status recommend Abemaciclib therapy.
Who Should Avoid Abemaciclib 150 mg?
Abemaciclib 150 mg should not be used by individuals with a known hypersensitivity to Abemaciclib or any of its ingredients. It is contraindicated in pregnant or breastfeeding women due to potential harm to the fetus or infant.
Caution is advised for patients with severe liver impairment or existing blood count disorders unless specifically recommended by a healthcare provider.
Consult your doctor if you have other serious health conditions before starting Abemaciclib therapy.
Side Effects of Abemaciclib 150 mg
- Diarrhea
- Nausea
- Vomiting
- Fatigue
- Neutropenia (low white blood cell count)
- Anemia
- Thrombocytopenia (low platelet count)
- Decreased appetite
- Abdominal pain
- Respiratory infections
- Elevated liver enzymes
- Rash
- Headache
Safety Advice
- Inform your doctor about all medications you are taking to avoid interactions.
- Regular blood tests are necessary to monitor blood counts and liver function.
- Report signs of infection or unusual bleeding immediately.
- Avoid pregnancy during treatment and use effective contraception.
- Do not stop treatment without consulting your healthcare provider.
- Maintain hydration and follow diet recommendations to manage gastrointestinal side effects.
Drug Interactions
- Do not combine with strong CYP3A4 inhibitors or inducers without medical advice.
- May interact with certain antifungal and antibiotic medications.
- Use caution with other drugs that suppress bone marrow function.
- Notify your doctor if you take blood thinners or hormone therapies.
Storage Instructions
Store Abemaciclib 150 mg tablets in a cool, dry place away from direct sunlight and moisture. Keep the medication out of reach of children and pets. Do not use the medicine beyond its expiration date. Proper storage helps maintain the drugโs potency and safety.
Where to buy Abemaciclib 150 mg in Malaysia?
Abemaciclib 150 mg is available through licensed pharmacies and authorized medical suppliers in Malaysia. Patients should obtain this medication with a valid prescription from an oncologist. Purchasing from legitimate sources ensures you receive authentic and safe products. Online pharmacies with proper accreditation may also stock this medicine, but verify credentials before ordering.
Frequently Asked Questions (FAQ)
What is the price of Abemaciclib 150 mg in Malaysia?
The price of Abemaciclib 150 mg in Malaysia varies depending on the pharmacy and availability. It is best to consult local licensed pharmacies or your healthcare provider for the most accurate and current pricing information.
What happens if I miss a dose?
If you miss a dose of Abemaciclib 150 mg, take it as soon as you remember unless it is near the time for your next scheduled dose. Do not double the dose to compensate. Contact your doctor if you are unsure about what to do.
Where can I find Abemaciclib 150 mg for sale?
You can find Abemaciclib 150 mg at authorized pharmacies and hospitals in Malaysia. It requires a prescription, so you will need to consult a healthcare professional to obtain it legally and safely.
Is Abemaciclib 150 mg available in Malaysia?
Yes, Abemaciclib 150 mg is available in Malaysia through licensed medical providers and pharmacies. It's important to purchase it through legitimate channels to ensure product safety.
Can I take Abemaciclib 150 mg with other cancer treatments?
Abemaciclib 150 mg is often prescribed alongside hormone therapies. However, combining it with other treatments should only be done under strict medical supervision to avoid harmful interactions.
What should I do if I experience severe side effects?
If you experience severe side effects such as persistent diarrhea, signs of infection, or unusual bleeding, contact your healthcare provider immediately. Prompt medical attention is essential for managing side effects.
How long does treatment with Abemaciclib 150 mg last?
The duration of treatment with Abemaciclib 150 mg depends on the patientโs response and tolerance. Your oncologist will tailor the therapy length based on your clinical progress and side effects.
Conclusion
Abemaciclib 150 mg is a potent and targeted treatment option for metastatic breast cancer patients, offering a valuable mechanism to control cancer progression. Manufactured by Eli Lilly and Company India, it adheres to high quality and safety standards. With proper medical guidance, adherence to treatment, and awareness of potential side effects, patients can benefit significantly from this therapy. Always consult your healthcare provider to ensure this medication is appropriate for your condition and to receive personalized dosing and safety advice.
No reviews yet.
Abemaciclib 150 mg (Generic) Is Out Of Stock
Sorry! Abemaciclib 150 mg (Generic) Is Out Of Stock.
Please click below to view other similar medications.

Abemaciclib 100 mg (Generic)
View Treatment
Leave A Review